Lehigh Valley Health Network

LVHN Scholarly Works
Department of Emergency Medicine

Does Performing Endoscopy Sooner Have an Impact on
Outcomes in Patients With Acute Nonvariceal Upper
Gastrointestinal Hemorrhage? A Systematic Review.
Zahid Ijaz Tarar
University of Missouri

Muhammad Usman Zafar
Umer Farooq
MacNeal Hospital

Ghulam Ghous
University of Missouri

Hafiz Muhammad Hassan Shoukat
Wright State University

See next page for additional authors

Follow this and additional works at: https://scholarlyworks.lvhn.org/emergency-medicine
Part of the Gastroenterology Commons

Published In/Presented At
Tarar, Z., Zafar, M., Farooq, U., Ghous, G., Shoukat, H., & Kuwajima, V. (2021). Does Performing Endoscopy
Sooner Have an Impact on Outcomes in Patients With Acute Nonvariceal Upper Gastrointestinal
Hemorrhage? A Systematic Review.. LVHN Scholarly Works. Retrieved from
https://scholarlyworks.lvhn.org/emergency-medicine/669

This Article is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion
in LVHN Scholarly Works by an authorized administrator. For more information, please contact
LibraryServices@lvhn.org.

Authors
Zahid Ijaz Tarar, Muhammad Usman Zafar, Umer Farooq, Ghulam Ghous, Hafiz Muhammad Hassan
Shoukat, and Vanessa Kuwajima

This article is available at LVHN Scholarly Works: https://scholarlyworks.lvhn.org/emergency-medicine/669

Open Access Original
Article

DOI: 10.7759/cureus.16092

Does Performing Endoscopy Sooner Have an
Impact on Outcomes in Patients With Acute
Nonvariceal Upper Gastrointestinal Hemorrhage?
A Systematic Review
Zahid Ijaz Tarar 1 , Muhammad Usman Zafar 2 , Umer Farooq 3 , Ghulam Ghous 4 , Hafiz Muhammad Hassan
Shoukat 5 , Vanessa Kuwajima 6
1. Internal Medicine, University of Missouri, Columbia, USA 2. Hospital Medicine, Lehigh Valley Health Network,
Allentown, USA 3. Internal Medicine, Loyola Medicine, MacNeal Hospital, Berwyn, USA 4. Hematology/Oncology,
University of Missouri, Columbia, USA 5. Internal Medicine, Premier Health/Wright State University, Dayton, USA 6.
Gastroenterology and Hepatology, University of Missouri, Columbia, USA
Corresponding author: Zahid Ijaz Tarar, drzahidejaz@hotmail.com

Abstract
Background
Endoscopy is the cornerstone for the diagnosis and treatment of nonvariceal upper gastrointestinal
bleeding. Regarding the management of nonvariceal bleeding, the administration of crystalloid solution and
proton pump inhibitors before endoscopy is well established, but the optimal timing of endoscopy has been
a matter of debate and a subject of many investigational studies. The need for urgent endoscopy arises to
provide prompt redress to acute bleeding, decrease the length of stay, and lower mortality from ongoing
bleeding.

Objective
This study aimed to determine if endoscopy performed within 24 hours of presentation improves outcomes
in terms of mortality, hospital length of stay, and rebleeding in individuals presenting with nonvariceal
upper gastrointestinal bleed with any risk.

Methodology
We performed a systematic review of two large databases (PubMed and Google Scholar) to incorporate all
studies published after 2000. We included studies with nonvariceal upper gastrointestinal bleeding and
excluded those reporting variceal gastrointestinal hemorrhage.

Results
Review began 06/01/2021
Review ended 06/19/2021
Published 07/01/2021
© Copyright 2021
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distributed under the terms of the
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We reviewed eight studies that qualified after meeting our inclusion and exclusion criteria. We divided these
studies into three separate groups based on the timing of endoscopy. Only two studies found a difference in
mortality that was statistically significant in patients who underwent endoscopy within 24 hours of
presentation. One study showed lower mortality in a patient who underwent urgent endoscopy, but it did
not reach statistical significance. Other studies did not show any statistical difference in mortality, hospital
length of stay, and rebleeding rates. The studies showed conflicting evidence on the amount of blood
transfusion, though urgent endoscopy was found to be difficult in few studies due to blood obscuring the
lesion.

Conclusions
While data suggest that there is a potential benefit in performing endoscopy sooner, there is no concrete
evidence to point to a particular time range. Before performing endoscopy, the American Society for
Gastrointestinal Endoscopy (2012) recommends adequate resuscitation with crystalloid solutions, blood
transfusions, and antisecretory and prokinetic agent therapy. More investigational studies are needed to
formulate a time-sensitive flow sheet to approach endoscopy in patients with nonvariceal upper
gastrointestinal bleeding. A strict criterion is also needed to delineate patients into low-risk and high-risk
groups. Doing so would provide a systematic approach to help with mortality, rebleeding, and healthcare
resource utilization.

Categories: Internal Medicine, Gastroenterology
Keywords: urgent upper endoscopy, esophagogastroduodenoscopy (egd), hemostasis, mortality, nonvariceal
hemorrhage
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Introduction
Nonvariceal upper gastrointestinal bleeding is one of the most common gastrointestinal tract problems with
a significant impact on the healthcare system, averaging 300,000 hospitalizations yearly with a total
expenditure of 7.6 billion US dollars. Endoscopy is the cornerstone for the diagnosis and treatment of
nonvariceal bleeding. Advancements in endoscopy techniques are proving beneficial in decreasing mortality
[1-3]. Endoscopy can identify the cause of bleeding in 80% of patients, yet mortality from peptic ulcer
disease, which is the most common cause of upper gastrointestinal bleeding, ranges between 5% and 14%.
This incidence is further increased in the elderly with multiple comorbidities [4-6].
The optimal timing for endoscopy has been a matter of debate and a subject of many investigational studies.
Recently, several authors have tried to tackle this question and determine whether patients need to be riskstratified to assess the appropriate timing. Although there is significant evidence that endoscopy performed
within 24 hours of presentation is beneficial in terms of mortality and rebleeding, there is limited data to
show how soon endoscopy should be performed [7,8]. Results from different studies yield conflicting results;
for example, in studies performed by Cho et al. and Lim et al., decreased mortality was found, but in similar
studies conducted by Tai et al. and Targownik et al., no significant difference was seen [9-12]. It is to be
noted that the population size was larger in the former studies which could be one reason for a significant
difference.
The need for urgent endoscopy arises to provide prompt redress to acute bleeding, decrease the length of
hospital stay, and lower mortality from ongoing bleeding. The decision to perform endoscopy could be
deferred in individuals with low-risk features, including age <60 years, those who do not have major
comorbidity, and are hemodynamically stable. Therefore, a criterion to stratify patients is needed. Some
scores have been developed and are useful in these instances. Two very well-known and validated scores are
the Glasgow-Blatchford score (GBS) and Rockall score which help in categorizing patients into low-risk and
high-risk groups [6,13]. Of these, GBS is considered superior. By dividing patients into low-risk and high-risk
groups, we can identify patients who would require endoscopy sooner. In an ideal setting, patients who
undergo prompt endoscopy with identification and treatment of the culprit lesion and are hemodynamically
stable should be discharged with outpatient monitoring. Hospital length of stay and resource utilization
would be affected by this. However, Bjorkman et al. were unable to find any difference in resource utilization
[14]. The theoretical benefits of urgent esophagogastroduodenoscopy (EGD) in providing source
identification and control, characterization of the lesion, and need for hospital admission exist but concrete
evidence is limited. In studies conducted by Laine et al. and Kodali et al., it was highlighted that patients
with clean ulcers were at low risk for recurrent bleeding and could be potentially managed in an outpatient
setting. This should help in resource utilization in the long term; however, provider behavior might be
variable with regards to admitting or discharging low-risk patients [15,16]. In Bjorkman et al., the decision to
admit a patient after endoscopy was taken by the admitting provider and not the endoscopists. The
admitting providers continued to admit patients despite being advised of the low risk of particular
patients [14].
Theoretically, if bleeding lesions are identified and treated earlier, one would hypothesize that the risk of
rebleeding would decrease and that there would be a mortality benefit and associated decrease in the length
of hospital stay, cost, and resource utilization. However, as is evident above, this has not been the case in a
majority of the studies reviewed.

Materials And Methods
We performed a literature search on two large public databases, namely, PubMed and Google Scholar, to
identify studies on the topic published after 2000. The following search words were used to identify studies
from Google Scholar: gastrointestinal bleeding, timing, endoscopy, nonvariceal, early, and delayed. A total
of 2,770 search results were obtained. A meticulous search was performed and studies meeting the following
exclusion criteria were not selected: (i) not in English, (ii) articles on variceal bleeding, (iii) Articles
involving complications of portal hypertension, (iv) articles on upper gastrointestinal hemorrhage that did
not compare early versus delayed nonvariceal bleeding, (v) review articles, and (vi) articles with clear
intervals not defined. Articles were reviewed by both reviewers and disagreements were resolved by
consensus. A total of 17 articles were identified in this manner from Google Scholar and 34 articles from
PubMed. After further discussion, articles with a mention of variceal bleeding and no further comments on
time intervals were excluded. After accounting for duplicates, eight studies were identified for review. These
studies were reviewed for the effectiveness of early endoscopy, primary outcomes on the patient population,
and economic effects from different time intervals (Figure 1).
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FIGURE 1: PRISMA flowchart describing study selection and inclusion
process.
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses

Results
After selecting articles for review, the studies were divided according to the time limit set for endoscopy. By
doing this, we wanted to analyze and compare studies that evaluated the same time period against each
other. We discuss the studies below.
Table 1 summarizes two studies that compared endoscopies done within eight hours of presentation to the
ones done 8-24 hours of presentation. In the first study, Tai et al. compared outcomes for patients who
presented to the emergency department with nonvariceal gastrointestinal bleeding and were deemed to be
at high risk. This was a retrospective study that identified 189 high-risk individuals (88 received endoscopy
within eight hours and the rest 101 within 8-24 hours) who presented to the emergency department (ED)
within a six-month time interval (July 2004 to December 2004). High-risk individuals were defined as age
more than 60 years, severe comorbidity, active bleeding (witnessed hematemesis, red blood per nasogastric
tube, hematochezia), hypotension or shock, red blood cell transfusion of more than six units, and severe
coagulopathy. The study had clearly defined inclusion and exclusion criteria. The comparison duration of
eight hours was selected because working hours were eight hours per day. This study did not find any
difference in transfusion rate, length of hospitalization, and mortality rate in both groups. The most
commonly found lesions on endoscopy were duodenal and gastric ulcers but without any statistical
difference between the two groups. Although the mortality rate was lower in the group undergoing
endoscopy within eight hours (1% vs, 6%), the data did not reach statistical significance, even though more
actively bleeding lesions were detected. One shortcoming in this study was that among the group that
underwent endoscopy within eight hours patients were found to retain more blood. This makes EGD more
difficult to complete, puts an individual at risk for bronchoaspiration, and necessitates repeat EGD.
Additionally, in this study, more patients underwent combined endoscopic therapeutic modalities in the
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early intervention group without any significant effect on outcomes.
The second study was carried out by Ahn et al. (Table 1). In contrast with the above study, this study
examined outcomes from urgent EGDs done “after hours” [17]. Data were obtained from procedures
performed between January 2009 to December 2010 in a tertiary hospital in Korea by two experienced
endoscopists. A total of 158 patients were included in the study based on admission timing “after hours,”
and out of these, 60 received endoscopy in eight hours and the rest 98 within 8-24 hours. The time limit for
the urgent EGD was set within eight hours from the initial admission. There was no difference in primary
outcomes among the two groups, which was defined as primary hemostasis, recurrent bleeding, and 30-day
mortality. There was no statistically significant difference in secondary outcomes defined as hospital length
of stay (although the length of hospital stay was higher in patients who underwent EGD within 8-24 hours),
transfusion requirements, and recurrent endoscopies. Similar to Tai et al., the most frequently found
bleeding lesion in this study was peptic ulcers. Patients in this study were also followed up two months postdischarge and had no recurrence of bleeding in either group. In a multiple linear regression analysis, they
found that urgent EGD (within eight hours) would decrease the hospital length of stay. The strength of this
study is that it chose to address the effect of urgent EGD after hours when staffing can be an issue.
Moreover, it followed patients two months post-discharge to evaluate any immediate adverse events. A
shortcoming, however, was that it did not have clearly defined inclusion/exclusion criteria, although the
patients were stratified using the Rockall score into low-risk and high-risk groups. In addition, although the
study put great emphasis on using experienced endoscopists for better outcomes, they were unable to
compare outcomes against inexperienced endoscopists. Both these studies looked at a smaller subset of
patients, and maybe a larger sample size would find some difference. Both studies did not address the role of
proton pump inhibitor (PPI) on endoscopic outcomes.

Source

Patients

Tai et
al.

189;

(2007)
[11]

Design

Outcome measured

Conclusion

Mortality rate, length of stay, total

No statistical difference regarding the rate of recurrent

high-risk
patients

Retrospective amount of transfusion, rate of
recurrent bleeding

158; all
risk

Retrospective

bleeding, total amount of transfusion, length of stay, and
mortality rate in both groups

Ahn et
al.
(2016)

Mortality and hospital length of
stay

Clinical outcomes were not significantly different between
the urgent and early EGD groups

[17]

TABLE 1: Comparison of outcomes in endoscopy performed within eight hours versus within 8-24
hours.
EGD: esophagogastroduodenoscopy

Table 2 lists studies that compared endoscopies performed within six hours of presentation against those
done 6-48 hours after presentation. A total of three studies were identified. The largest of these was
conducted in Korea by Cho et al. The study included 961 patients that were deemed to be high risk with
nonvariceal bleeding. This retrospective observational study examined patients with a GBS greater than 7
who presented to their emergency department. The data spanned a period of nine years. Compared to
patients who underwent endoscopy within six hours (urgent) versus those who underwent endoscopy within
48 hours (delayed), the study found significant differences in mortality rate, the number of transfused
packed red blood cells, need for intervention, and embolization among the study groups. The mortality rate
was higher among the delayed group. The need for transfusion, intervention, and embolization was higher
among the urgent group. The study found no difference in rebleeding, intensive care unit admission,
vasopressor use, and length of stay. The study had strict inclusion/exclusion criteria. Variceal bleeding and
tumor bleeding were excluded. All patients were initiated on PPI. This study had several strengths including
strong inclusion and exclusion criteria, patients with GBS of >7 in the high-risk group compared to previous
studies that only included patients with GBS of >12, and it found increased mortality among patients with
malignancy and cirrhosis independently. Limitations of this study included that it did not compare
endoscopies on low-risk patients, patients were observed only at one hospital, and it included patients with
malignancy and cirrhosis that had the potential to skew data.
Bjorkman et al. (Table 2) aimed to observe outcomes of patients with nonvariceal upper gastrointestinal
bleeding in clinical settings where non-gastroenterologists were decision-makers. This was done in lieu of a
highly structured study because patients presenting in a real-world setting may not be evaluated by a strict
criterion. This study was a prospective, randomized, blinded, and multicenter trial that compared patients
undergoing endoscopy within six hours (urgent) versus those undergoing within 48 hours (elective). The
study did not include patients considered to be high risk, as determined by hemodynamic instability and a
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Rockall score of 6 or 7. Data were analyzed with the intention to treat. The study did not find any difference
in primary outcomes defined as healthcare resource utilization (length of stay, intensive care unit days,
blood transfusions, and the need for additional interventions) or patient outcomes. It is to be noted that the
study was terminated early because an interim analysis showed that continuing the study would not alter the
primary outcomes so only 93 outpatients were studied. However, because mortality rate and recurrent
bleeding were secondary outcomes, it was not determined if extending the study would have affected the
outcomes. A strength of this study is that the disposition of the patient was determined by the attending and
not the investigator endoscopist which allowed to obtain real-life data analysis. The admitting provider
chose to admit patients despite being labeled as low risk. It can be debated that the outcomes would have
been different if the patients were discharged instead, but this decision was allowed by the study design.
Targownik et al. (Table 2) reviewed patients who presented to two different tertiary care centers in Canada
with acute nonvariceal upper gastrointestinal bleeding between 1999 and 2004. The inclusion criteria
delineated 169 patients into two groups, in which one group underwent endoscopy within six hours (rapid)
and the other had endoscopy within 24 hours (early). The study was limited to individuals with
hemodynamic instability as defined by systolic blood pressure <100 mmHg and heart rate >100 beats per
minute. Data from the rapid group reached statistical significance for having more active bleeding,
nonbleeding visible vessels, or an adherent clot when compared to the early group. Patients undergoing
urgent endoscopy were less likely to receive PPI which could affect the study because it has been shown that
prior use of PPI can improve visualization of lesions. This study failed to identify any statistical significance
in primary outcomes (25% rapid group versus 23% early group; P > 0.2) such as in-hospital rebleeding, inhospital mortality, any surgical intervention, and 30-day readmission. Although a decrease in the likelihood
of developing adverse gastrointestinal outcomes was seen in the rapid endoscopy group, this was not
statistically significant (odds ratio [OR]: 1.16; 95% confidence interval [CI]: 0.53-2.52). Like other studies in
the ongoing discussion, this study was limited by sample size as well. Additional shortcomings were a lack of
structured PPI use and a lack of controls.

Source

Patients

Design

Outcome measured

Conclusion
Urgent endoscopy was an

Cho et al.

961;

(2018) [9]

high risk

Retrospective Mortality and rebleeding within 28 days of admission

independent predictor of lower
mortality rate and was not
associated with rebleeding in
high-risk patients with acute
nonvariceal UGIB

Bjorkman
et al.
(2004) [14]

Targownik
et al.
(2007) [12]

93; all
risk

169;
high risk

Randomized
prospective
clinical trial

30-day resource utilization, including the number of
hospital days (total length of stay), ICU days. Blood
transfusion, and the need for additional intervention
(surgery, endoscopy, radiology). Secondary outcomes
included the frequency of recurrent bleeding, mortality
rate, and other morbidities
Development of any adverse bleeding outcome

Retrospective (rebleeding, surgery for control of bleeding, in-hospital
mortality, or readmission within 30 days for ANVUGIB

Urgent endoscopy did not
reduce hospitalization or
resource utilization

No significant difference in
adverse bleeding outcomes

TABLE 2: Comparison of outcomes in endoscopy performed within six hours versus within 6-48
hours.
ICU: intensive care unit; UGIB: upper gastrointestinal bleeding; ANVUGIB: acute nonvariceal upper gastrointestinal bleeding

Table 3 summarizes the three studies that compared endoscopies done within 24 hours against those
performed within 12-13 hours. Lim et al. studied 934 patients over a period of 18 months prospectively and
divided them into low- and high-risk groups based on a GBS of 12. All patients with a GBS less than 12 were
considered low risk and those above 12 were included in the high-risk group. Of the 934 patients, 97 met the
criteria for high risk, and the rest 837 were low risk. The primary outcome measured in this study was allcause in-hospital mortality. The study compared outcomes in low- and high-risk patients who received EGD
in 13 hours versus after 13 hours. Inclusion and exclusion criteria were clearly defined and all patients with
variceal bleeding and lower gastrointestinal bleed confirmed on colonoscopy were excluded. The study
found that high-risk patients required more endoscopic treatment, blood transfusion, ICU admission, and
rebleeding episodes compared with low-risk patients. In high-risk patients who underwent endoscopy after
13 hours, all-cause mortality was very high (44% to 0%), with a statistical significance of <0.001, and these
patients all had decrease length of stay without a large difference in blood transfusion needs, rebleeding
rates, or subsequent surgery. On the other hand, in low-risk patients, endoscopy after 13 hours was not
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associated with an increase in all-cause mortality. Additionally, the authors performed a subgroup analysis
on 725 patients who received EGD with 24 hours and after 24 hours due to various reasons to determine that
if GBS of 12 and above still yield similar results if EGD is done within 13 hours. This subgroup analysis
verified the previous results of decreased mortality in high-risk patients who received EGD within 13 hours
compared to those who underwent EGD after 13 hours (0% vs 48%) with a P-value of <0.001. The analysis
also confirmed that there was no difference in mortality in low-risk groups based on EGD timings. An
unfortunate drawback to this study was that the sample size of high-risk versus low-risk was small
potentially adding bias to the study.
Saleem et al. (Table 3) conducted a retrospective observational study of patients who frequented a tertiary
hospital in upstate New York in a year between January and December with an upper gastrointestinal
bleed. Of the 806 charts reviewed by the authors, 251 patients were included in the analysis. These patients
were divided into three groups: those who received EGD in <12 hours of admission (urgent endoscopy), 1224 hours of admission (early endoscopy), and >24 hours after admission (late endoscopy). Similar to the
discussion above, the authors found significant differences in the presence of blood obscuring the scope and
timing of EGD. This was one of the reasons why patients in the urgent EGD group underwent a second EGD.
No differences in length of hospital stay, the number of units of blood, and mortality were identified with
respect to the timing of EGD. The upside to this study was that the patients had similar risk based on the
Blatchford scores and no difference in mortality and hospital length of stay was found. This review was
limited by its retrospective nature.
The study by Jairath et al. (Table 3) is one of the largest studies in this review that included 212 UK hospitals
studying 4,478 patients. Data were collected for two months on patients with acute upper gastrointestinal
bleeding in these centers. Similar to Saleem et al., patients were grouped into three groups based on
endoscopy performed within 12 hours, 12-24 hours, or >24 hours. No difference in mortality was seen
between those who underwent endoscopy early (<12 hours) and those examined later (12-24 hours, OR: 0.99,
95% CI: 0.97-1.02; or >24 hours OR: 0.98, 95% CI: 0.88-1.09; P = 0.7). Patients who underwent endoscopy
earlier experienced rebleeding more than the other two groups (19.7% vs. 10.9% vs. 8.8%, respectively;
unadjusted ORs for rebleeding 0.75, 95% CI 0.69-0.81 at 12-24 hours; 0.63, 95% CI 0.56-0.72 at >24 hours; P
< 0.001). However, after adjusting for confounding variables, no difference was seen. This study
demonstrated a reduction in risk-adjusted length of stay and found that early endoscopy led to improved
control of hemorrhage in high-risk patients. One of the strong points of this study was that it used a mixedeffects logistic regression model to examine the relationship between time to endoscopy and mortality to
adjust for confounding variables.

Source

Patients

Lim et
al.

934; all

(2011)
[10]

risk

Design

Outcomes measured

Prospective

All-cause in-hospital mortality

Saleem
et al.
(2020)

(2012)
[25]

Lower mortality in high-risk but not in low-risk
patients

Mortality, hospital length of stay, or
250; all
risk

Retrospective

[21]
Jairath
et al.

Conclusion

number of blood transfusions received,
surgical or interventional radiology-

No difference in mortality, number of units of blood
transfused, or length of hospitalization

guided interventions

4,478;

Randomized

Mortality, rebleeding, need for surgery,

all risk

control trial

and length of hospital stay

No reduction in mortality or need for surgery.
However, there was increased efficiency of acre and
potentially improved control of hemorrhage in highrisk patients

TABLE 3: Comparison of outcomes in endoscopy performed within 13 hours versus within 13-24
hours.

Discussion
Endoscopy is the most effective method for diagnosing and treating nonvariceal gastrointestinal bleeding
[18]. Current guidelines recommend performing endoscopy within 24 hours in high-risk patients who are
hemodynamically unstable, have a hemoglobin of <8 g/dL, or present with shock. For patients with
suspected variceal bleed, however, guidelines recommend performing endoscopy within 12 hours [19]. No
such recommendations exist for bleeding due to causes other than variceal hemorrhage. Various studies
have been performed to study the benefit for patients undergoing endoscopy for nonvariceal hemorrhage
within 24 hours of admission. Our review focused on studies that ascertained the benefit of endoscopy in
nonvariceal hemorrhage sooner than 24 hours.
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The only studies that showed mortality benefit in this review were Cho et al. and Lim et al. [9,10]. In the
study by Tai et al., the mortality rate was lower in the group that received endoscopy sooner; however, this
data did not reach statistical significance [11]. In the study by Cho et al., the focus was rightfully set on highrisk individuals, and while the study did find mortality benefits, it is interesting to know that the patients
who received endoscopy sooner also were transfused larger blood volumes and were more likely to receive
intervention than the delayed group. While this could potentially skew data, there was no difference in
rebleeding. Lim et al. have been criticized for including a small sample of high-risk patients and doubt has
been shed on the study’s design. Having a larger sample size gives the study by Cho et al. a potential
advantage. In a study done on more than one million Medicare beneficiaries undergoing endoscopy, a
mortality benefit was likely found due to the large sample size [20].
Before performing endoscopy, the American Society for Gastrointestinal Endoscopy (2012) recommends
adequate resuscitation with crystalloid solutions and blood transfusion in hemodynamically unstable
patients followed by antisecretory and prokinetic agent therapy. Some of the studies above did not have a
strict criterion for PPI use before endoscopy. In these studies, it was observed that in patients who
underwent endoscopy sooner, more active bleeding was found, and it was more likely that in these patients
the bleeding obscured the primary lesion [11,12,21]. Previous data have shown that gastric visualization
improves with agents introduced prior to endoscopy like PPI or prokinetic agents [22-24].
Lim et al. and Jairath et al. noticed differences in rebleeding rates in the groups that underwent endoscopy
sooner [10,25]. Overall, no difference was found among other studies. As mentioned by Cho et al., rebleeding
was understandably more evident in patients with high-risk lesions, and these patients were more likely to
undergo endoscopy sooner [9]. While not all studies had structured PPI use as mentioned above, studies that
did use PPI argue that the time between PPI use and urgent EGD might be short enough that minimal
healing occurred. This might have prompted findings of more active bleeding and/or increased the risk of
rebleeding.
Resource utilization and hospital length of stay can be directly affected by the timing of endoscopy [26]. If
we can identify patients who have had a gastrointestinal bleed but are at low risk, they could potentially be
discharged from the hospital with outpatient follow-up. Bjorkman et al. set out to study these parameters.
However, they were unable to identify any difference in healthcare utilization by performing endoscopy
earlier [14]. The decision to admit patients after endoscopy was delegated to admitting providers, and
despite being informed about the low risk, these patients were still admitted. More studies are needed to
accurately predict these parameters and to instill confidence in decision-makers to send stable patients
home with outpatient follow-up.
There are some limitations of our review. This review includes mostly retrospective studies, and more
randomized controlled trials are needed to elucidate differences in the timing of endoscopy. Additionally,
studies characterized subjects into high-risk and low-risk based on different criteria, although there were
several similar risk factors. Our review could also be limited by publication bias where one seeks to publish
favorable outcomes. However, we have followed PRISMA guidelines for systematic review and discussed
relevant points from all studies after agreement from authors. While we have limited evidence suggesting
mortality benefit from endoscopy performed sooner than 24 hours, more work needs to be done to identify
patients that would benefit from this procedure, a clear definition of early endoscopy, appropriate
guidelines to recommend discharge for patients at low risk, and utilization of these recommendations for
better healthcare cost and utilization.

Conclusions
Even though the data is suggestive of potential benefit in performing endoscopy sooner, there is no concrete
evidence to point to a particular time range. With regards to the management of nonvariceal bleeding, the
following aspects are clear. On arrival, the patient should have intravenous access and receive crystalloid
solutions and PPI. While we have limited evidence suggesting mortality benefit from endoscopy performed
earlier than 24 hours, more work needs to be done to identify patients who would benefit from this
procedure, a clear definition of early endoscopy, appropriate guidelines to recommend discharge for patients
at low risk, and utilization of these recommendations for better healthcare cost and utilization. More large
center prospective studies are needed to formulate a time-sensitive flowsheet to approach endoscopy in
patients with nonvariceal upper gastrointestinal bleeding.
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